Skip to main content
IMTX logo
IMTX
(NASDAQ)
Immatics N.V.
$10.35-- (--)
Loading... - Market loading

Immatics (IMTX) Stock Price & Financial Analysis

Immatics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$9.78 - $10.66
52-Week High$12.41
52-Week Low$3.30
Open$9.78
Volume423.21K
Average Volume (3M)423.21K
Market Cap1.30B
Shares Outstanding126.05M
Price to Sales (P/S)22.75
Price to Book (P/B)2.26
EV/EBITDA-3.96
Revenue (TTM)55.40M
Net Income (TTM)-217.40M
Free Cash Flow (TTM)-210.30M
EPS (TTM)$-1.72
Profit Margin-392.44%
Operating Margin-373.07%
Return on Equity (ROE)-38.99%
Debt to Equity0.03
50-Day MA$9.83
200-Day MA$8.52
52-Week Change150.25%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Immatics

What is the current stock price for IMTX?

As of the latest trading session, IMTX stock trades at $10.35. The 52-week range is $3.30–$12.41, with a day range of $9.78–$10.65.

What is the P/E ratio for IMTX?

The P/E ratio (Price-to-Earnings) for IMTX is shown in the Key Statistics section. This valuation metric helps compare Immatics N.V. to industry peers.

Does IMTX pay dividends?

Immatics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IMTX?

Based on 1 analyst, the consensus for IMTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IMTX?

Immatics's market capitalization is $1.30B, classifying it as a small-cap company. Immatics operates in the Healthcare sector within the Biotechnology industry.